Your session is about to expire
← Back to Search
dTMS for Smoking Cessation in Schizophrenia
Study Summary
This trial will study how dTMS affects brain chemistry in people with schizophrenia, and how this might help reduce smoking in this vulnerable population. #schizophrenia #smoking #dTMS #PET #brainchemistry
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I understand the information given to me and can make decisions about my health care.I am currently using products to help me stop smoking.I have been diagnosed with a schizophrenia spectrum disorder.I have a history of serious neurological issues or use medication that increases seizure risk.I am between 18 and 60 years old.I am diagnosed with a nicotine addiction and want to reduce or stop smoking.I have been hospitalized within the last 3 months.I have been diagnosed with a schizophrenia spectrum disorder.
- Group 1: Active deep transcranial magnetic stimulation (dTMS)
- Group 2: Sham
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this clinical trial consider geriatric individuals as participants?
"This experiment seeks individuals aged 18 or more and under 60 for inclusion."
Are there still openings for potential participants in this investigation?
"As per the information stored on clinicaltrials.gov, this experiment is not presently recruiting volunteers. Originally posted on February 1st 2023 and last updated January 27th 2023, though there are 530 other studies actively enrolling patients now."
May I have the opportunity to partake in this exploration?
"The ideal candidate for this research is between 18 and 60 years old, with a schizophrenia diagnosis. As of now, the study requires 38 individuals to participate."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger